"Platinum(II) dichlorido and oxalato (ox) complexes of the composition cis-[PtCl2(Haza)(2)] (I) and [Pt(ox) (Haza)(2)].H2O(II.H2O) were prepared by a one-step syntheses from K-2[PtCl4] and K-2[Pt(ox)(2)].2H2O, respectively (Haza symbolises 7-azaindole). The complexes were characterised by a set of spectroscopic methods (IR, Raman and multinuclear and 2D NMR), as well as by mass spectrometry, elemental (C, H, and N) and thermal (TG/DTA) analyses. Single-crystal X-ray analysis was performed for cis-[PtCl2(Haza)(2)].DMF (I.DMF) and [Pt(ox)(Haza)(2)] (II), obtained by recrystallization of the complexes I and II center dot H2O from N,N'-dimethylformamide (DMF). Both complexes, of a square-planar geometry, involve a tetracoordinated central Pt(II) atom with two monodentate N7-coordinated 7-azaindole molecules in cis-positions, and with the coordination sphere completed by two chloride anions (I; PtN2Cl2 donor set) or one bidentate-coordinated oxalate dianion (II: PtN2O2 donor set). The complexes did not show any in vitro cytotoxic effect, as evaluated by an MTT assay against breast adenocarcinoma and osteosarcoma human cancer cell lines up to a concentration of 1.0 uM (for I) and 0.1 uM (for II.H2O), given by their limited solubility in the medium used." . . "000300643100054" . "In vitro cytotoxicity; Multinuclear NMR; X-ray structure; 7-Azaindole; Platinum(II) complexes"@en . "Cisplatin and oxaliplatin derivatives involving 7-azaindole: Structural characterisations"@en . "RIV/61989592:15310/12:33140839!RIV13-MSM-15310___" . "[2E931C1D46E4]" . "\u0160tarha, Pavel" . "Polyhedron" . . . . "1" . . "127291" . . . "3"^^ . "Tr\u00E1vn\u00ED\u010Dek, Zden\u011Bk" . . "Cisplatin and oxaliplatin derivatives involving 7-azaindole: Structural characterisations" . . "http://ac.els-cdn.com/S0277538711007510/1-s2.0-S0277538711007510-main.pdf?_tid=f290745e-7b5e-11e2-813b-00000aacb361&acdnat=1361366030_ee722d46031401e078f413732a8289f411007510" . . . . . "3"^^ . . "Marek, Jarom\u00EDr" . . "0277-5387" . "33" . "Platinum(II) dichlorido and oxalato (ox) complexes of the composition cis-[PtCl2(Haza)(2)] (I) and [Pt(ox) (Haza)(2)].H2O(II.H2O) were prepared by a one-step syntheses from K-2[PtCl4] and K-2[Pt(ox)(2)].2H2O, respectively (Haza symbolises 7-azaindole). The complexes were characterised by a set of spectroscopic methods (IR, Raman and multinuclear and 2D NMR), as well as by mass spectrometry, elemental (C, H, and N) and thermal (TG/DTA) analyses. Single-crystal X-ray analysis was performed for cis-[PtCl2(Haza)(2)].DMF (I.DMF) and [Pt(ox)(Haza)(2)] (II), obtained by recrystallization of the complexes I and II center dot H2O from N,N'-dimethylformamide (DMF). Both complexes, of a square-planar geometry, involve a tetracoordinated central Pt(II) atom with two monodentate N7-coordinated 7-azaindole molecules in cis-positions, and with the coordination sphere completed by two chloride anions (I; PtN2Cl2 donor set) or one bidentate-coordinated oxalate dianion (II: PtN2O2 donor set). The complexes did not show any in vitro cytotoxic effect, as evaluated by an MTT assay against breast adenocarcinoma and osteosarcoma human cancer cell lines up to a concentration of 1.0 uM (for I) and 0.1 uM (for II.H2O), given by their limited solubility in the medium used."@en . "Cisplatin and oxaliplatin derivatives involving 7-azaindole: Structural characterisations"@en . . . . "6"^^ . "P(ED2.1.00/03.0058), P(EE2.3.20.0017), P(GAP207/11/0841), S" . "GB - Spojen\u00E9 kr\u00E1lovstv\u00ED Velk\u00E9 Brit\u00E1nie a Severn\u00EDho Irska" . . "RIV/61989592:15310/12:33140839" . . . "10.1016/j.poly.2011.11.059" . "Cisplatin and oxaliplatin derivatives involving 7-azaindole: Structural characterisations" . . "15310" . .